Previous 10 | Next 10 |
Ekso Bionics Holdings, Inc. (EKSO) Q3 2020 Earnings Conference Call October 29, 2020 4:30 PM ET Company Participants David Carey - IR, Lazar Partners Ltd. Jack Peurach - President & Chief Executive Officer Bill Shaw - Chief Commercial Officer Jack Glenn - Chief Financial Officer Conferenc...
Ekso Bionics Holdings (EKSO): Q3 GAAP EPS of -$0.01 beats by $0.38.Revenue of $2.89M (-13.0% Y/Y) beats by $0.44M.Press Release For further details see: Ekso Bionics Holdings EPS beats by $0.38, beats on revenue
RICHMOND, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended September 30, 2020. ...
A c utting-edge endurance-boosting assistive device , E VO is designed to reduce the risk of repetitive or fatigue-related injuries for construction workers and other industrial employees RICHMOND, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, In...
RICHMOND, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2020 after the close of trad...
Ekso Bionics has continued to dilute its equity over the past year, and more of the same appears likely in the next 12 to 18 months. The FDA approval for use of the Ekso therapy exoskeleton with patients suffering from brain injury is a promising development to help move sales along a...
RICHMOND, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer of Ekso Bionics, will present at the H.C. Wainwright 22nd An...
RICHMOND, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”) , an industry leader in exoskeleton technology for medical and industrial use, today unveiled EVO TM , an endurance-boosting assistive upper body exos...
Start Time: 16:30 End Time: 17:00 Ekso Bionics Holdings, Inc. (EKSO) Q2 2020 Earnings Conference Call July 30, 2020, 16:30 PM ET Company Participants Jack Peurach - President and CEO Jack Glenn - CFO Bill Shaw - Chief Commercial Officer David Carey - IR, Lazar Partners Ltd....
Ekso Bionics Holdings (NASDAQ: EKSO ) : Q2 GAAP EPS of -$1.88 misses by $1.32 . More news on: Ekso Bionics Holdings, Inc., Earnings news and commentary, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Ekso Bionics Holdings Inc. Website:
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2...
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”...